High-resolution myocardial perfusion imaging in mice with high-frequency echocardiographic detection of a depot contrast agent.

High-resolution methods for assessing myocardial perfusion in murine models of cardiovascular disease are needed. We hypothesized that regional hypoperfusion could be assessed with ultrahigh-frequency myocardial contrast echocardiography (MCE) and a novel strategy of depot contrast enhancement. MCE was performed with 30-MHz transthoracic imaging 10 seconds and 10 minutes after intravenous administration of microbubbles in control mice, and in mice after left anterior descending coronary artery ligation. MCE was also performed using size-segregated microbubbles. Microbubble behavior in the microcirculation was evaluated with intravital microscopy. In control mice anterior myocardial enhancement was robust at 10 seconds, but left ventricular cavity attenuation precluded evaluation of posterior segments. After 10 minutes, left ventricular cavity signal cleared but myocardial enhancement persisted, permitting analysis of all segments. The degree of enhancement at 10 min was related to microbubble size, implying retention of large microbubbles transiting pulmonary arteriovenous shunts. Intravital microscopy confirmed capillary lodging of large microbubbles. Infarct size by delayed MCE correlated with fluorescent nanospheres (r = 0.94, P < .001). We conclude that complete assessment of regional myocardial perfusion in the mouse heart is possible with high-frequency MCE and a single intravenous contrast agent injection. This technique can be used for characterizing murine models of myocardial infarction and left ventricular remodeling.

[1]  W J Manning,et al.  In vivo assessment of LV mass in mice using high-frequency cardiac ultrasound: necropsy validation. , 1994, The American journal of physiology.

[2]  K. Ley,et al.  Ultrasound Assessment of Inflammation and Renal Tissue Injury With Microbubbles Targeted to P-Selectin , 2001, Circulation.

[3]  J. Gardin,et al.  Echocardiographic assessment of left ventricular mass and systolic function in mice. , 1995, Circulation research.

[4]  D. Sahn,et al.  Ultrasound-mediated destruction of contrast agents. Effect of ultrasound intensity, exposure, and frequency. , 1997, Investigative radiology.

[5]  S. Kaul,et al.  Noninvasive imaging of inflammation by ultrasound detection of phagocytosed microbubbles. , 2000, Circulation.

[6]  J I Hoffman,et al.  Blood flow measurements with radionuclide-labeled particles. , 1977, Progress in cardiovascular diseases.

[7]  J. Ross,et al.  Transthoracic echocardiography in models of cardiac disease in the mouse. , 1996, Circulation.

[8]  J. Murgo,et al.  Microsphere and dilution techniques for the determination of blood flows and volumes in conscious mice. , 1992, The American journal of physiology.

[9]  P. Hunziker,et al.  Echocardiographic determination of risk area size in a murine model of myocardial ischemia. , 1999, American journal of physiology. Heart and circulatory physiology.

[10]  R. Walsh,et al.  In vivo echocardiographic detection of enhanced left ventricular function in gene-targeted mice with phospholamban deficiency. , 1995, Circulation research.

[11]  S. Kaul,et al.  Assessment of Endogenous and Therapeutic Arteriogenesis by Contrast Ultrasound Molecular Imaging of Integrin Expression , 2005, Circulation.

[12]  N de Jong,et al.  Absorption and scatter of encapsulated gas filled microspheres: theoretical considerations and some measurements. , 1992, Ultrasonics.

[13]  Jiri Sklenar,et al.  Microvascular rheology of Definity microbubbles after intra-arterial and intravenous administration. , 2002, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[14]  L. Frizzell,et al.  Attenuation coefficient estimates of mouse and rat chest wall , 2001, IEEE Transactions on Ultrasonics, Ferroelectrics and Frequency Control.

[15]  A R Jayaweera,et al.  Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion. , 1998, Circulation.

[16]  P. Lacelle,et al.  Capillary diameter in rat heart in situ: relation to erythrocyte deformability, O2 transport, and transmural O2 gradients. , 1976, Microvascular research.

[17]  O. V. Evgenov,et al.  NOS3 deficiency augments hypoxic pulmonary vasoconstriction and enhances systemic oxygenation during one-lung ventilation in mice. , 2005, Journal of applied physiology.

[18]  A. Casadevall,et al.  Immunoglobulin G Monoclonal Antibodies to Cryptococcus neoformans Protect Mice Deficient in Complement Component C3 , 2002, Infection and Immunity.

[19]  S. Kaul,et al.  Influence of microbubble surface charge on capillary transit and myocardial contrast enhancement. , 2002, Journal of the American College of Cardiology.